Antimicrobial Efficacy Assessment of Human Derived Composite Amnion-Chorion Membrane

Nathan D Palanker1, Chun-Teh Lee1, Robin L Weltman1

  • 1The University of Texas Health Science Center at Houston School of Dentistry, Houston, Texas, 77054, USA.

Scientific Reports
|November 1, 2019
PubMed

Insights

Human derived composite amnion-chorion membrane (ACM) demonstrated potent antimicrobial properties against oral bacteria. This biomaterial completely inhibited bacterial growth in vitro, unlike control membranes.

Area of Science:

  • Biomaterials Science
  • Microbiology
  • Regenerative Medicine

Background:

  • Human derived composite amnion-chorion membrane (ACM) is utilized for wound healing, with known anti-inflammatory and cell proliferation benefits.
  • Assessing the antimicrobial efficacy of biomaterials like ACM is crucial for their clinical application.

Purpose of the Study:

  • To evaluate the in situ antimicrobial properties of ACM against oral streptococci.
  • To introduce novel methods for visualizing membrane antimicrobial efficacy.

Main Methods:

  • ACM and Porcine Pericardium Collagen Membranes (PPCM) were tested using insert, agar contact, and glass-bottom well assays.
  • Streptococcus gordonii were applied to membranes, followed by centrifugation and incubation.
  • Live/Dead BacLight staining and confocal microscopy were used to assess bacterial viability at 8, 24, and 48 hours.

Main Results:

  • ACM exhibited complete inhibition of bacterial growth across all tested time points.
  • PPCM controls showed no significant antimicrobial activity.
  • Confocal microscopy visualized the high antimicrobial efficacy of ACM in situ.

Conclusions:

  • ACM demonstrates significant antimicrobial efficacy against oral streptococci.
  • The developed methods are suitable for assessing antimicrobial properties of biomaterials with limited diffusion.
  • ACM shows potential as an antimicrobial agent in oral applications.